Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Neuroblastoma × Blood Specimen Collection × Clear all

Phase

Phase NA 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 37 Neoplasms 35 Lung Neoplasms 23 Colorectal Neoplasms 20 Carcinoma, Non-Small-Cell Lung 18 Prostatic Neoplasms 12 Ovarian Neoplasms 11 Melanoma 11 Pancreatic Neoplasms 9 Neoplastic Cells, Circulating 8 Neoplasm Metastasis 8 Multiple Myeloma 8 Head and Neck Neoplasms 8 Uterine Cervical Neoplasms 7 Sarcoma 7 Hematologic Neoplasms 7 Glioma 7 Glioblastoma 7 Colonic Neoplasms 7 Lymphoma 6 Leukemia, Myeloid, Acute 6 Carcinoma, Hepatocellular 6 Urinary Bladder Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Peritoneal Neoplasms 4 Lymphoma, Follicular 4 Hodgkin Disease 4 Fibrosis 4 Brain Neoplasms 4 Uveal Melanoma 3

Interventions

Therapeutics 3 Isotretinoin 3 Etoposide 3 Cyclophosphamide 3 Vincristine 2 Stem Cell Transplantation 2 Radiotherapy, Image-Guided 2 Radiotherapy 2 Psychiatric Rehabilitation 2 Melphalan 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 Granulocyte Colony-Stimulating Factor 2 Dexamethasone 2 Cisplatin 2 Carboplatin 2 Calcium Dobesilate 2 Aprepitant 2 sargramostim 1 pegfilgrastim 1 humanized 3F8 anti-GD2 monoclonal antibody 1 hetrombopag 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 Traumeel S 1 Topotecan 1 Sugars 1 Spermine Synthase 1 Ropivacaine 1 Radiation 1 Polymerase Chain Reaction 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02864563 2023-12-01

PHRCNB07

Institut Curie

Phase NA Completed

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡